- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Pseudobulbar Affect (PBA) In Geriatric & Long-Term Care Patients
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Pseudobulbar Affect (PBA) In Geriatric & Long-Term Care Patients
PBA is a neurologic condition that occurs secondary to a variety of otherwise unrelated neurologic conditions and is characterized by sudden, frequent, uncontrollable episodes of laughing and/or crying.1,2 Residents in long-term care settings with PBA symptoms may have different characteristics with their medication usage or behavioral symptoms compared to those residents without PBA symptoms.3,4 In this webinar, our panelists will be reviewing PBA characteristics, neurocircuitry and pathophysiology, PBA prevalence, the impact of PBA on patients and assessment of PBA symptoms.
References:-
1. Cummings JL, et al. CNS Spectr. 2006;11(6):1-7
2. Wortzel HS, et al. CNS Drugs. 2008; 22(7):531-545
3. Foley K et al. Int J Geriatr Psychiatry. 2016;31:694-701
4. Zarowitz BJ, et al. Consultant Pharm. 2013;28:713-22Featuring
Justin Rash, PharmD, BCGP (OPDC)
Senior Medical Science Liaison
Michelle Lavagnino, DrPH(c) (OPDC)
Medical Science Liaison, Long-term Care
Justin Rash and Michelle Lavagnino are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Clinical Perspectives on the Impact of Agitation in Alzheimer’s Dementia Among the Hispanic Community
September 18 12:00 pm to 1:00 pm
Registration
Related Resources
-
Rural Minds – Mental Health in Rural America, Jeff Winton
Podcast Episode July 24, 2024Listen to Amica Simmons-Yon, PharmD, PhD as she spills the tea on mental health in rural America with special guest, Jeff Winton (Founder of Rural Minds). During this episode, Jeff…
-
Multiple States Easing Formulary Restrictions On Antipsychotics
Article July 24, 2024Nevada can now be added to the growing list of states that have enacted legislation to exempt antipsychotics from step therapy (ST) and prior authorization (PA) protocols. The legislation (Nevada…
-
Practical Application of Wellness Strategies for Individuals in Underserved Communities with Major Depressive Disorder (MDD) & Post-Traumatic Stress Disorder (PTSD)
On-Demand Webinar July 12, 2024Approximately 50 million United States adults are living with a mental illness, with 21 million having depression and 13 million with post-traumatic stress disorder.1-4 Minority individuals are among these prevalence…
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: